PATENT CLAIM ANALYSIS

Application Number: 15936129
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "439000"]

Abstract:
Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.

Claim (Index 6):
The packaged syrup of  claim 10 , wherein said Regulatory Guidelines are the United States FDA Final Monograph for dextromethorphan hydrobromide.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 2.10714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12630365', '10298175', '15713746', '10121706', '13272031']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7275941229183283
- 35 USC 102 Novelty (BERT): 0.5043628804739176
- Combined Prediction Score: 0.7052709986738872
- Mean Citation Score: 171.233082
- Max Citation Score: 177.86311
- Similarity Product: 100.96630909046829

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test